Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252185 | SCV000308098 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000724913 | SCV000332383 | uncertain significance | not provided | 2015-06-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724913 | SCV000721809 | likely benign | not provided | 2020-06-01 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000680490 | SCV000807868 | likely benign | Connective tissue disorder | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000724913 | SCV001595435 | likely benign | not provided | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004609335 | SCV005103878 | likely benign | Inborn genetic diseases | 2024-05-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |